Variants in the 5q31 cytokine gene cluster are associated with psoriasis

Genes and Immunity

Volumn 9, Issue 2, 2008, Pages 176-181

  Chang, M ^a   Li, Y ^a   Yan, C ^a   Callis Duffin, K P ^b   Matsunami, N ^b   Garcia, V E ^a   Cargill, M ^a   Civello, D ^a   Bui, N ^a   Catanese, J J ^a   Leppert, M F ^b,c   Krueger, G G ^b   Begovich, A B ^a   Schrodi, S J ^a  

^a CELERA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c LineaGen Research Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA C ANTIGEN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5;

ALLELE; ARTICLE; CASE CONTROL STUDY; CELLULAR IMMUNITY; CHROMOSOME 5Q; CONTROLLED STUDY; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 5; CYTOKINES; HAPLOTYPES; HUMANS; MULTIGENE FAMILY; PSORIASIS; VARIATION (GENETICS);

EID: 40449113452     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364451     Document Type: Article

References (34)

1. Farber EM, Nall L. Epidemiology: Natural history and genetics. In: Roenigk HH, Maibach HI (eds). Psoriasis, 3rd edn. Marcel Dekker Inc.: New York, 1998, pp 107-158.
2. Naldi L. Inflammatory skin diseases IV: Psoriasis. In: Williams HC, Strachan DP (eds). The Challenge of Dermato-epidemiology. CRC Press: Boca Raton, FL, 1997, pp 175-180.
3. Green AC. Australian Aborigines and psoriasis. Australas J Dermatol 1984; 25: 18-24.
4. Convit J. Investigation of the incidence of psoriasis amongst Latin-American Indians. In: Fitzpatrick T, Eisen A, Wolff, K, Freedberg I, Austen K (eds). Dermatology in General Medicine, 4th edn. The McGraw-Hill Companies, New York, 1993, pp 489-493.
5. Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: Epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 ii18-ii23.
6. Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-271.
7. Bowcock AM. The genetics of psoriasis and autoimmunity. Annu Rev Genomics Hum Genet 2005; 6: 93-122.
8. Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78: 827-851.
9. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP et al A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273-290.
10. Weir BS. Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sinauer: Sunderland, MA, 1996.
11. Sokal RR, Rohlf FJ. Biometry, 3rd edn. WH Freeman and Company: New York, 1995.
12. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
13. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K et al Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000; 9: 549-559.
14. Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, Kakinuma T et al Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci 2002; 30: 100-107.
15. Cancino-Diaz JC, Reyes-Maldonado E, Banuelos-Panuco CA, Jimenez-Zamudio L, Garcia-Latorre E, Leon-Dorantes G et al. Interleukin-13 receptor in psoriatic keratinocytes: Overexpression of the mRNA and underexpression of the protein. J Invest Dermatol 2002; 119: 1114-1120.
16. Janssens AC, Moonesinghe R, Yang Q, Steyerberg EW, van Duijn CM, Khoury MJ. The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 2007; 9: 528-535.
17. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003; 19: 376-382.
18. Friberg C, Bjorck K, Nilsson S, Inerot A, Wahlstrom J, Samuelsson L. Analysis of chromosome 5q31-32 and psoriasis: Confirmation of a susceptibility locus but no association with SNPs within SLC22A4 and SLC22A5. J Invest Dermatol, 2006; 126: 998-1002.
19. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-1870.
20. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001; 29: 223-228.
21. Mirza MM, Fisher SA, King K, Cuthbert AP, Hampe J, Sanderson J et al Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet 2003 72: 1018-1022.
22. Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447: 661-678.
23. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CIM et al. Genetic susceptibility to asthma: Bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333: 894-900.
24. Howard TD, Whittaker PA, Zaiman AL, Koppelman GH, Xu J, Hanley MT et al. Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population. Am J Respir Cell Mol Biol 2001; 25: 377-384.
25. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
26. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R et al. CARD15 mutations in Blau syndrome. Nat Genet 2001; 29: 19-20.
27. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-338.
28. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75 330-337.
29. Neimann AL, Porter SB, Gelfand JM. The epidemiology of psoriasis. Expert Rev Dermatol 2006; 1: 63-75.
30. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ et al A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463.
31. Lesueur F, Oudot T, Heath S, Foglio M, Lathrop M, Prud'homme JF et al ADAM33, a new-candidate for psoriasis susceptibility. PLoS ONE 2007; 2: E906.
32. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
33. Silverberg MS, Duerr RH, Brant SR, Bromfield G, Datta JW, Jani N et al. Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur J Hum Genet 2007; 15: 328-335.
34. Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007; 122: 201-206.